EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Remote digital cognitive assessment in a trial‐ready Alzheimer's disease cohort: A scalable approach for early intervention studies

Andrew J Aschenbrenner iD, Hannah Wilks, Matthew Welhaf, Samhita Katteri, Sarah H Stout, Martin J Sliwinski, Tammie L S Benzinger, Brian Gordon, Yan Li, Richard J Perrin, Alan Renton, Guoqiao Wang und 14 weitere

Alzheimer's & Dementia: Translational Research & Clinical Interventions · 2026-07 · 12 (3)

DOI: 10.1002/trc2.70311 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia: Translational Research & Clinical Interventions, online erschienen am 08.09.2026. Verfasst von Andrew J Aschenbrenner und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology University of Kansas Medical Center Kansas City Kansas USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, Alzheimer's Association, Eli Lilly and Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Early detection of cognitive decline in Alzheimer's disease (AD), particularly in preclinical stages, is critical for evaluating therapeutic interventions. Traditional cognitive assessments often require lengthy in‐person visits, and may therefore limit scalability for younger, trial‐ready populations for primary and secondary prevention studies. We evaluated the feasibility, reliability, and validity of high‐frequency remote digital cognitive assessments in individuals with autosomal dominant AD (ADAD). METHODS One hundred twenty‐three mutation carriers and non‐carriers from the Dominantly Inherited Alzheimer Network Trials Unit from 20 international sites (Ages 19–66 years) completed remote assessments via personal smartphones, prompted four times daily for 7 days (≈ 3 minutes per session), and conventional in‐clinic cognitive testing at baseline. Adherence, between‐person reliability, test–retest reliability (intraclass correlation coefficients [ICCs]), construct validity (confirmatory factor analysis), and sensitivity to clinical disease progression were evaluated. RESULTS Remote measures demonstrated excellent reliability (ICCs > 0.90 after just 10 sessions) and strong construct validity, with tasks loading onto memory, attention, and executive function domains. A composite of the remote tests slightly outperformed a traditional composite at separating mutation carriers from non‐carriers. Average adherence to the study protocol was 42%, lower that observed in previous studies of older adults. DISCUSSION High‐frequency remote cognitive assessment is feasible, reliable, and valid in a relatively young international ADAD cohort. This approach offers substantial utility for clinical trials, including improved accessibility and enhanced reliability, supporting its integration into early‐intervention studies.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer's diseaseclinical trialscognitive testingdigital assessmentremote monitoring

Autor:innen und Institutionen

  • Department of Neurology University of Kansas Medical Center Kansas City Kansas USA.
  • Department of Psychological and Brain Sciences Washington University in St. Louis St. Louis Missouri USA.
  • Department of Psychology North Carolina A&T State University Greensboro North Carolina USA.
  • Department of Neurology Washington University in St. Louis St. Louis Missouri USA.
  • Human Development and Family Studies Pennsylvania State University University Park Pennsylvania USA.
  • Department of Radiology Washington University in St. Louis St. Louis Missouri USA.

ORCID-Profile: Andrew J Aschenbrenner

Förderung

  • NIA NIH HHS
  • Alzheimer's Association
  • Eli Lilly and Company
  • Avid Radiopharmaceuticals
  • GHR Foundation

Zitieren

APA

Aschenbrenner, A. J., Wilks, H., Welhaf, M., Katteri, S., Stout, S. H., Sliwinski, M. J., Benzinger, T. L. S., Gordon, B., Li, Y., Perrin, R. J., Renton, A., Wang, G., Xiong, C., van Dyck, C. H., Allegri, R., Brooks, W. S., Bechara, J. A., Jayadev, S., Levin, J., …, & Hassenstab, J. (2026). Remote digital cognitive assessment in a trial‐ready Alzheimer's disease cohort: A scalable approach for early intervention studies. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 12(3). https://doi.org/10.1002/trc2.70311

Vancouver

Aschenbrenner AJ, Wilks H, Welhaf M, Katteri S, Stout SH, Sliwinski MJ, et al. Remote digital cognitive assessment in a trial‐ready Alzheimer's disease cohort: A scalable approach for early intervention studies. Alzheimer's & Dementia: Translational Research & Clinical Interventions. 2026;12(3). doi:10.1002/trc2.70311

BibTeX
@article{Aschenbrenner2026,
  author = {Aschenbrenner, Andrew J and Wilks, Hannah and Welhaf, Matthew and Katteri, Samhita and Stout, Sarah H and Sliwinski, Martin J and Benzinger, Tammie L S and Gordon, Brian and Li, Yan and Perrin, Richard J and Renton, Alan and Wang, Guoqiao and Xiong, Chengjie and van Dyck, Christopher H and Allegri, Ricardo and Brooks, William S and Bechara, Jacob A and Jayadev, Suman and Levin, Johannes and Mummery, Catherine J and Sanchez-Valle, Raquel and Aguillon, David and McDade, Eric M and Bateman, Randall J and Dominantly Inherited Alzheimer Network Trials Unit (DIAN‐TU), Dominantly Inherited Alzheimer Network Trials Unit (DIAN‐TU) and Hassenstab, Jason},
  title = {Remote digital cognitive assessment in a trial‐ready Alzheimer's disease cohort: A scalable approach for early intervention studies},
  journal = {Alzheimer's & Dementia: Translational Research & Clinical Interventions},
  year = {2026},
  volume = {12},
  number = {3},
  doi = {10.1002/trc2.70311}
}
Kostenlos starten →